Lymphocyte activation test for diagnosis of seronegative Brucellosis in humans

Background: Seronegative brucellosis is occasionally encountered in clinical practice especially in localized disease where diagnosis is reached mainly through positive blood culture. Cellular immune responses are pivotal for protection against intracellular bacteria such as Brucella. This study was...

Full description

Bibliographic Details
Main Author: Fahad M Almajid
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2011-01-01
Series:Indian Journal of Pathology and Microbiology
Subjects:
Online Access:http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2011;volume=54;issue=4;spage=775;epage=781;aulast=Almajid
id doaj-ff0ecf1e8cfc4d95a03ba153b928d49c
record_format Article
spelling doaj-ff0ecf1e8cfc4d95a03ba153b928d49c2020-11-24T23:48:54ZengWolters Kluwer Medknow PublicationsIndian Journal of Pathology and Microbiology0377-49292011-01-0154477578110.4103/0377-4929.91499Lymphocyte activation test for diagnosis of seronegative Brucellosis in humansFahad M AlmajidBackground: Seronegative brucellosis is occasionally encountered in clinical practice especially in localized disease where diagnosis is reached mainly through positive blood culture. Cellular immune responses are pivotal for protection against intracellular bacteria such as Brucella. This study was performed to evaluate the expression of activation markers on peripheral blood mononuclear cells in response to in vitro stimulation by whole-cell suspension of Brucella melitensis for the diagnosis of brucellosis. Materials and Methods: Fifteen seronegative patients with positive blood cultures for Brucella and twenty-five unexposed healthy blood donors serving as controls were recruited for the study. Peripheral blood mononuclear (PBMC) cells were obtained by the method of Ficoll Hypaque density gradient and stimulated in vitro with Brucella antigen. Expression of activation markers was assessed by flow cytometry after staining of PBMC with mononuclear cells with relevant monoclonal antibodies. Results: Incubation with mitogen induced expression of all the four markers was demonstrated in all blood samples. In contrast, samples from all patients of Brucellosis showed significant positive responses with the expression of activation markers (CD38, CD69, CD25, and CD71) on both CD4+ and CD8+ cells as compared with the control group (P < 0.001). Conclusion: It is inferred that there was a remarkable upregulation of activation markers on CD4+ and CD8+ in seronegative patients with Brucellosis. It is recommended that the method can be utilized as a novel diagnostic test for detection of brucellosis where serology is negative.http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2011;volume=54;issue=4;spage=775;epage=781;aulast=AlmajidDiagnosisimmune systemlymphocyteseronegative brucellosis
collection DOAJ
language English
format Article
sources DOAJ
author Fahad M Almajid
spellingShingle Fahad M Almajid
Lymphocyte activation test for diagnosis of seronegative Brucellosis in humans
Indian Journal of Pathology and Microbiology
Diagnosis
immune system
lymphocyte
seronegative brucellosis
author_facet Fahad M Almajid
author_sort Fahad M Almajid
title Lymphocyte activation test for diagnosis of seronegative Brucellosis in humans
title_short Lymphocyte activation test for diagnosis of seronegative Brucellosis in humans
title_full Lymphocyte activation test for diagnosis of seronegative Brucellosis in humans
title_fullStr Lymphocyte activation test for diagnosis of seronegative Brucellosis in humans
title_full_unstemmed Lymphocyte activation test for diagnosis of seronegative Brucellosis in humans
title_sort lymphocyte activation test for diagnosis of seronegative brucellosis in humans
publisher Wolters Kluwer Medknow Publications
series Indian Journal of Pathology and Microbiology
issn 0377-4929
publishDate 2011-01-01
description Background: Seronegative brucellosis is occasionally encountered in clinical practice especially in localized disease where diagnosis is reached mainly through positive blood culture. Cellular immune responses are pivotal for protection against intracellular bacteria such as Brucella. This study was performed to evaluate the expression of activation markers on peripheral blood mononuclear cells in response to in vitro stimulation by whole-cell suspension of Brucella melitensis for the diagnosis of brucellosis. Materials and Methods: Fifteen seronegative patients with positive blood cultures for Brucella and twenty-five unexposed healthy blood donors serving as controls were recruited for the study. Peripheral blood mononuclear (PBMC) cells were obtained by the method of Ficoll Hypaque density gradient and stimulated in vitro with Brucella antigen. Expression of activation markers was assessed by flow cytometry after staining of PBMC with mononuclear cells with relevant monoclonal antibodies. Results: Incubation with mitogen induced expression of all the four markers was demonstrated in all blood samples. In contrast, samples from all patients of Brucellosis showed significant positive responses with the expression of activation markers (CD38, CD69, CD25, and CD71) on both CD4+ and CD8+ cells as compared with the control group (P < 0.001). Conclusion: It is inferred that there was a remarkable upregulation of activation markers on CD4+ and CD8+ in seronegative patients with Brucellosis. It is recommended that the method can be utilized as a novel diagnostic test for detection of brucellosis where serology is negative.
topic Diagnosis
immune system
lymphocyte
seronegative brucellosis
url http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2011;volume=54;issue=4;spage=775;epage=781;aulast=Almajid
work_keys_str_mv AT fahadmalmajid lymphocyteactivationtestfordiagnosisofseronegativebrucellosisinhumans
_version_ 1725484052497039360